We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+8.15%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$287B
AUM Growth
+$27.6B
Cap. Flow
+$6.59B
Cap. Flow %
2.29%
Top 10 Hldgs %
12.98%
Holding
8,864
New
808
Increased
4,307
Reduced
2,684
Closed
688

Sector Composition

Rank Sector Weight
1 Technology 9.82%
2 Financials 7.38%
3 Healthcare 6.65%
4 Consumer Discretionary 5.46%
5 Industrials 5.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MYOK
8576
PUT
DELISTED
MyoKardia, Inc. Common Stock
MYOK
-5,000
Closed -$261K
KBLMR
8577
DELISTED
KBL Merger Corp. IV Rights expiring 11/9/2020
KBLMR
-3,612
Closed -$1K
DCHF
8578
DELISTED
Exchange-Traded Notes linked to the VelocityShares Daily 4X Long USD vs. CHF Index due December 6, 2
DCHF
$0 ﹤0.01%
+5
New +$145
UEUR
8579
DELISTED
Exchange-Traded Notes linked to the VelocityShares Daily 4X Long EUR vs. USD Index due December 6, 2
UEUR
$0 ﹤0.01%
10
-1,200
-99% -$18.6K
LMFAW
8580
DELISTED
LM Funding America, Inc. Warrant
LMFAW
$0 ﹤0.01%
26,849
FMCIW
8581
DELISTED
Forum Merger II Corporation Warrant
FMCIW
$0 ﹤0.01%
364
-336
-48% -$187
AKCA
8582
DELISTED
Akcea Therapeutics Inc
AKCA
-27,244
Closed -$419K
AMTD
8583
PUT
DELISTED
TD Ameritrade Holding Corp
AMTD
-1,000
Closed -$47K
RWIU
8584
DELISTED
Direxion FTSE Russell International Over US ETF
RWIU
$0 ﹤0.01%
+1
New +$53
FPAC.WS
8585
DELISTED
Far Point Acquisition Corporation Warrants, exercisable for one share of Class A Common Stock for $1
FPAC.WS
-1,600
Closed -$2K
PLCY
8586
DELISTED
EventShares U.S. Legislative Opportunities ETF
PLCY
-2,217
Closed -$48K
RYCE
8587
DELISTED
Amira Nature Foods Ltd
RYCE
$0 ﹤0.01%
+51
New +$377
PVAL
8588
DELISTED
Principal Contrarian Value Index ETF
PVAL
$0 ﹤0.01%
10
-146
-94% -$4.02K
EYEGW
8589
DELISTED
Eyegate Pharmaceuticals, Inc. Warrants
EYEGW
$0 ﹤0.01%
3,600
+3,490
+3,173% +$118
AGFSW
8590
DELISTED
AgroFresh Solutions Inc Warrants
AGFSW
$0 ﹤0.01%
4,400
+3,350
+319% +$30
TLRD
8591
PUT
DELISTED
Tailored Brands, Inc.
TLRD
-467,400
Closed -$2.06M
LM
8592
PUT
DELISTED
Legg Mason, Inc.
LM
-197,500
Closed -$7.54M
HCR
8593
PUT
DELISTED
Hi-Crush Inc. Common Stock
HCR
-20,000
Closed -$35K
DSLV
8594
DELISTED
VelocitySharesTM 3x Inverse Silver ETN linked to the S&P GSCI Silver Inverse Index ER
DSLV
-2,804
Closed -$53K
EASI
8595
DELISTED
Amplify EASI Tactical Growth ETF
EASI
-71
Closed -$2K
GPAQW
8596
DELISTED
Gordon Pointe Acquisition Corp. Warrant
GPAQW
$0 ﹤0.01%
+197
New +$69
JPED
8597
DELISTED
JPMorgan Event Driven ETF
JPED
$0 ﹤0.01%
8
-764
-99% -$19.9K
SDRL
8598
DELISTED
Seadrill Limited Common Stock
SDRL
$0 ﹤0.01%
257
-46,794
-99% -$77.5K
VAM
8599
DELISTED
Vivaldi Opportunities Fund
VAM
-526
Closed -$7K
SRTSW
8600
DELISTED
Sensus Healthcare, Inc. Warrant expiring on 06/08/2020
SRTSW
$0 ﹤0.01%
303
-97
-24% -$19

Similar funds

UBS Group's Q4 2019 Portfolio in Review

As of Q4 2019, UBS Group held 8,864 positions worth $287B, up 11% from $260B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group's Q4 2019 filing shows 808 new, 4,307 increased, 2,684 reduced and 688 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.3B.

By sector, the portfolio is most concentrated in Technology at 9.8% of assets, up from 9.5% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M.
  • UBS Group added most to UBS Group in Q4 2019, an estimated $1.48B increase.
  • UBS Group's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.3B.
  • UBS Group fully exited Altaba Inc in Q4 2019, selling an estimated $759M.
  • UBS Group's ten largest holdings make up 13% of its $287B portfolio in Q4 2019.
  • UBS Group opened 808 new positions and closed 688 in Q4 2019.
  • UBS Group's portfolio value rose 11% quarter-over-quarter to $287B.

Based on UBS Group's 13F filing for Q4 2019, filed 14 Feb 2020.